277 filings
Page 12 of 14
8-K
vuqvkrmfaefb
13 Jul 10
Entry into a Material Definitive Agreement
12:00am
8-K
9yal g204k
29 Jun 10
Enteromedics Announces 1-FOR-6 Reverse Split of Common Stock
12:00am
8-K
xp57lt
22 Jun 10
Regulation FD Disclosure
12:00am
8-K
r49cu1
19 May 10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ggo311a
11 May 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
45pzumqt505d5tahagac
21 Apr 10
EnteroMedics Reports First Quarter 2010 Financial Results
12:00am
8-K
z0psna
19 Apr 10
Departure of Directors or Certain Officers
12:00am
8-K
to6uy0w
17 Mar 10
EnteroMedics Extends Neuroblocking Technology Research and Development
12:00am
8-K
4u536qg4
15 Mar 10
EnteroMedics Announces Submission of IDE Application for Maestro RC System
12:00am
8-K
h20v2c643e
23 Feb 10
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
12:00am
8-K
a83k5s
12 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
45wue2
10 Feb 10
Departure of Directors or Certain Officers
12:00am
8-K
8u7gl076eo7n 45hz
28 Jan 10
EnteroMedics Reports Fourth Quarter and Full Year 2009 Financial Results
12:00am
8-K
sriav zv5rq5r72ukx
28 Jan 10
EnteroMedics Announces Regulatory Path Forward Following FDA Meeting
12:00am
8-K
p2mldm4
21 Jan 10
EnteroMedics Announces Transfer of its Common Stock to the Nasdaq Capital Market
12:00am
8-K
es4js81c3qf 91ez
20 Jan 10
Entry into a Material Definitive Agreement
12:00am
8-K
l4g 4y70go3
15 Jan 10
Enteromedics Announces $4.8 Million Financing
12:00am
8-K
oozxi6 h2m
14 Jan 10
Regulation FD Disclosure
12:00am
8-K
x3awy2os0r
19 Nov 09
EnteroMedics Receives Notice of NASDAQ Listing Deficiencies
12:00am
8-K
akd1ll804x1ysys fo5p
12 Nov 09
Enteromedics Announces Preliminary Results from Detailed
12:00am